(HeadStart 4) Newly Diagnosed Children (Less than 10 Years Old) With Medulloblastoma and Other Central Nervous System Primitive Neuro-Ectodermal Tumors: Clinical and Molecular Risk-Tailored Intensive and Compressed Induction Chemotherapy Followed by Consolidation with Either Single-Cycle (Low Risk Patients) or Randomization (High Risk Patients) to either Single-Cycle or to Three Tandem Cycles of Marrow-Ablative Chemotherapy with Autologous Hematopoietic Progenitor Cell Rescue
This research study will compare two different treatment regimens to see which is better for treating children with different types of brain tumors called medulloblastoma and CNS embryonal tumors of the brain or spinal cord.
- 0 - 10 years old
- Disease: Brain tumor
- Disease type: Medulloblastoma, Central Nervous System Embryonal Tumors
For additional information about eligibility criteria, please contact the study coordinator Jennifer King:
- Drug: Induction
- Drug type: Chemotherapy
For additional information about study procedures, please contact the study coordinator Jennifer King:
KeywordsBrain tumor - children, Central nervous system, Tumor, chemotherapy
Principal InvestigatorSridharan Gururangan, FRCP
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.